Cargando…
Expanding Access to COVID-19 Tests through US Postal Service Facilities
Widespread, convenient access to COVID-19 testing has been challenging in the United States. We make a case for provisioning COVID-19 tests through the United States Postal Service (USPS) facilities and demonstrate a simple method for selecting locations to improve access. We provide quantitative ev...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780264/ https://www.ncbi.nlm.nih.gov/pubmed/33124494 http://dx.doi.org/10.1177/0272989X20969690 |
_version_ | 1783631474247860224 |
---|---|
author | Singh, Bismark Risanger, Simon Morton, David Pignone, Michael Meyers, Lauren Ancel |
author_facet | Singh, Bismark Risanger, Simon Morton, David Pignone, Michael Meyers, Lauren Ancel |
author_sort | Singh, Bismark |
collection | PubMed |
description | Widespread, convenient access to COVID-19 testing has been challenging in the United States. We make a case for provisioning COVID-19 tests through the United States Postal Service (USPS) facilities and demonstrate a simple method for selecting locations to improve access. We provide quantitative evidence that even a subset of USPS facilities could provide broad access, particularly in remote and at-risk communities with limited access to health care. Based on daily travel surveys, census data, locations of USPS facilities, and an established care-seeking model, we estimate that more than 94% of the US population would be willing to travel to an existing USPS facility if warranted. For half of the US population, this would require traveling less than 2.5 miles from home; for 90%, the distance would be less than 7 miles. In Georgia, Illinois, and Minnesota, we estimate that testing at USPS facilities would provide access to an additional 4.1, 3.1, and 1.3 million people and reduce the median travel distance by 3.0, 0.8, and 1.2 miles, respectively, compared with existing testing sites per 28 July 2020. We also discuss the option of distributing test-at-home kits via USPS instead of private carriers. Finally, our proposal provides USPS an opportunity to increase revenues and expand its mission, thus improving its future prospects and relevance. |
format | Online Article Text |
id | pubmed-7780264 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-77802642021-01-13 Expanding Access to COVID-19 Tests through US Postal Service Facilities Singh, Bismark Risanger, Simon Morton, David Pignone, Michael Meyers, Lauren Ancel Med Decis Making Rounds Widespread, convenient access to COVID-19 testing has been challenging in the United States. We make a case for provisioning COVID-19 tests through the United States Postal Service (USPS) facilities and demonstrate a simple method for selecting locations to improve access. We provide quantitative evidence that even a subset of USPS facilities could provide broad access, particularly in remote and at-risk communities with limited access to health care. Based on daily travel surveys, census data, locations of USPS facilities, and an established care-seeking model, we estimate that more than 94% of the US population would be willing to travel to an existing USPS facility if warranted. For half of the US population, this would require traveling less than 2.5 miles from home; for 90%, the distance would be less than 7 miles. In Georgia, Illinois, and Minnesota, we estimate that testing at USPS facilities would provide access to an additional 4.1, 3.1, and 1.3 million people and reduce the median travel distance by 3.0, 0.8, and 1.2 miles, respectively, compared with existing testing sites per 28 July 2020. We also discuss the option of distributing test-at-home kits via USPS instead of private carriers. Finally, our proposal provides USPS an opportunity to increase revenues and expand its mission, thus improving its future prospects and relevance. SAGE Publications 2020-10-30 2021-01 /pmc/articles/PMC7780264/ /pubmed/33124494 http://dx.doi.org/10.1177/0272989X20969690 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Rounds Singh, Bismark Risanger, Simon Morton, David Pignone, Michael Meyers, Lauren Ancel Expanding Access to COVID-19 Tests through US Postal Service Facilities |
title | Expanding Access to COVID-19 Tests through US Postal Service
Facilities |
title_full | Expanding Access to COVID-19 Tests through US Postal Service
Facilities |
title_fullStr | Expanding Access to COVID-19 Tests through US Postal Service
Facilities |
title_full_unstemmed | Expanding Access to COVID-19 Tests through US Postal Service
Facilities |
title_short | Expanding Access to COVID-19 Tests through US Postal Service
Facilities |
title_sort | expanding access to covid-19 tests through us postal service
facilities |
topic | Rounds |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780264/ https://www.ncbi.nlm.nih.gov/pubmed/33124494 http://dx.doi.org/10.1177/0272989X20969690 |
work_keys_str_mv | AT singhbismark expandingaccesstocovid19teststhroughuspostalservicefacilities AT risangersimon expandingaccesstocovid19teststhroughuspostalservicefacilities AT mortondavid expandingaccesstocovid19teststhroughuspostalservicefacilities AT pignonemichael expandingaccesstocovid19teststhroughuspostalservicefacilities AT meyerslaurenancel expandingaccesstocovid19teststhroughuspostalservicefacilities |